Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia

Aim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia. Methods. Retrospective evaluation of a cohort of all Roma patients treated with pegylated interferon al...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sylvia Drazilova, Martin Janicko, Pavol Kristian, Ivan Schreter, Branislav Kucinsky, Marek Kozlej, Ivana Hockickova, Peter Jarcuska
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2016/8682494
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis
by: Jakub Gazda, et al.
Published: (2021-01-01)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01)

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01)

Early assessment of treatment response in primary biliary cholangitis: key to timely management
by: Tomas Koky, et al.
Published: (2025-08-01)

IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease
by: Sylvia Drazilova, et al.
Published: (2021-01-01)

Pegylated-interferon-alpha treatment modulating the immune response of cytotoxic lymphocytes in cervical intraepithelial neoplasia
by: Letícia Montes Stark, et al.
Published: (2021-06-01)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01)

Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
by: Priscilla C Hsu, et al.
Published: (2008-01-01)

Poverty, segregation and social exclusion of Roma communities in Slovakia
by: Rochovská Alena, et al.
Published: (2018-12-01)

Comparative efficacy and safety of pegylated interferon-alpha monotherapy vs combination therapies with entecavir or tenofovir in chronic hepatitis B patients
by: Huiqing Liang, et al.
Published: (2025-05-01)

Causes of health disadvantages and consequences of stigmatization in the Roma community in Slovakia
by: Sandra Ort-Mertlová, et al.
Published: (2025-01-01)

Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience
by: Bojović Ksenija, et al.
Published: (2020-01-01)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.
by: Upkar S Gill, et al.
Published: (2016-08-01)

Lagging regions of Slovakia in the context of their competitiveness
by: Pavol Korec
Published: (2014-03-01)

Migration in the Results of the Population Census 1921 a 1930 in Slovakia / Sťahovanie obyvateľstva vo výsledkoch sčítaní ľudu 1921 a 1930 na Slovensku
by: TIŠLIAR, Pavol, et al.
Published: (2024-06-01)

A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data
by: Ya-mei Ye, et al.
Published: (2024-12-01)

Hepatitis C Drugs: The End of the Pegylated Interferon Era and the Emergence of All-Oral, Interferon-Free Antiviral Regimens: A Concise Review
by: Alan Hoi Lun Yau, et al.
Published: (2014-01-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
by: Ertugrul Guclu, et al.
Published: (2014-12-01)

Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
by: Piotr Milkiewicz, et al.
Published: (2005-01-01)

Interferon Alpha Association with Neuromyelitis Optica
by: Nasrin Asgari, et al.
Published: (2013-01-01)

Content blocking mechanism in cybersecurity: Slovakia case study
by: Pavol Sokol, et al.
Published: (2025-02-01)

Exploring CJD incidence trends: insights from Slovakia
by: Pavol Skacik, et al.
Published: (2024-12-01)

Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.
by: Jeffrey A Gold, et al.
Published: (2007-08-01)

Deficit Water Volume in Hnilec River in Slovakia
by: Patrik NAGY, et al.
Published: (2025-03-01)

Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat
by: Bassem Refaat, et al.
Published: (2015-01-01)

Mode of Delivery by Maternal Characteristics: The Case of C-sections in Slovakia
by: Pavol Ďurček, et al.
Published: (2024-03-01)

Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon
by: Patrícia Alessandra Dastoli, et al.
Published: (2011-02-01)

On the Possibility of Using the Topical form of the Recombinant Interferon alpha-2b Drug in the Prevention of Acute Respiratory Viral Infections in Organized Groups
by: M. P. Kostinov, et al.
Published: (2024-05-01)

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy
by: Ružić Maja, et al.
Published: (2018-01-01)

Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study
by: Yiran Xie, et al.
Published: (2022-01-01)

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)
by: A. V. Chzhao, et al.
Published: (2018-08-01)

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia
by: Lilin Wang, et al.
Published: (2025-08-01)

The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial
by: Wenqi Huang, et al.
Published: (2025-05-01)

Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report
by: Bing Tian, et al.
Published: (2025-01-01)

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir
by: Csilla Putz-Bankuti, et al.
Published: (2013-01-01)

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
by: Gerrit-Jan Liefers, et al.
Published: (2020-11-01)

Innovation performance of EU countries in context of R&D: R&D trap risk in Slovakia?
by: Katarína Belanová, et al.
Published: (2025-06-01)

Response to Pegylated Interferon Plus Ribavirin in Patients with Hepatitis C Virus Genotype 6a Infection from Guangdong and Guangxi Province of China
by: Wangxia Tong, et al.
Published: (2016-01-01)